Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Biocon LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532523NSE Symbol: BIOCONP/E(TTM):0
ISIN Demat:INE376G01013Div & Yield %:0.12EPS(TTM):0.6
Book Value(Rs):119.5408865Market Cap ( Cr.):50757.82Face Value(Rs):5
    Change Company 
Date Headline
07-Jan-26 Stock Alert: Biocon, Senco Gold, Jubilant Foodworks, Titan Company
06-Jan-26 Biocon Biologics to introduce three new biosimilar oncology assets
23-Dec-25 Biocon arm secures global rights for Hulio from Fujifilm Kyowa Kirin Biologics Co
23-Dec-25 Biocon Ltd soars 0.1%, rises for fifth straight session
19-Dec-25 Stock Alert: Reliance Inds, Lupin, TCS, HCL Tech
15-Dec-25 Biocon launches GLP-1 peptide, Liraglutide in the Netherlands
15-Dec-25 Biocon launches its diabetes & obesity treatment drugs in Netherlands
13-Dec-25 Biocon’s arm inks pact to commercialize biosimilar Aflibercept Worldwide
06-Dec-25 Biocon Biologics to merge with Biocon
06-Dec-25 Biocon schedules EGM
<< < 1 2 3 4   > >>